In short
Baxdrostat, also known as CIN-107, is a novel drug being studied in clinical trials for the treatment of hypertension (high blood pressure). This aldosterone synthase inhibitor is showing promise in helping patients with uncontrolled and resistant hypertension who have not responded adequately to other medications. The trials are evaluating Baxdrostat's safety, efficacy, and how it interacts with other drugs in the body.
At a glance
- Drug Name
- Baxdrostat (also known as CIN-107)
- Drug Class
- Aldosterone synthase inhibitor
- Target Condition
- Uncontrolled hypertension and resistant hypertension
- Dosages Studied
- 1 mg, 2 mg, 3 mg, 10 mg oral tablets
- Administration
- Once daily oral dose
- Primary Outcomes
- Changes in systolic and diastolic blood pressure
- Secondary Outcomes
- Pharmacokinetics, safety, tolerability
- Study Populations
- Adults with uncontrolled or resistant hypertension, healthy volunteers
- Trial Phases
- Phase 1 and Phase 3 studies
- Key Measurements
- Office blood pressure, 24-hour ambulatory blood pressure, plasma drug concentrations, adverse events
What is Baxdrostat?
Baxdrostat, also known as CIN-107, is a new medication being developed to treat high blood pressure (hypertension). It belongs to a class of drugs called aldosterone synthase inhibitors. Baxdrostat is currently undergoing clinical trials to evaluate its effectiveness and safety in treating various forms of hypertension, including uncontrolled hypertension and resistant hypertension.
How Baxdrostat Works
Baxdrostat works by inhibiting an enzyme called aldosterone synthase. Aldosterone is a hormone that plays a crucial role in regulating blood pressure by controlling the balance of salt and water in the body. By blocking the production of aldosterone, Baxdrostat aims to lower blood pressure in patients who have not responded well to other treatments.
Conditions Treated by Baxdrostat
Baxdrostat is being studied for the treatment of several types of hypertension:
- Uncontrolled Hypertension: This refers to high blood pressure that remains above target levels despite treatment with two or more medications, including a diuretic.
- Resistant Hypertension: This is a more severe form of hypertension that persists despite treatment with three or more medications, including a diuretic.
Clinical Trials and Research
Several clinical trials are currently underway to evaluate Baxdrostat's effectiveness and safety:
- Phase 3 studies are examining the drug's ability to lower systolic blood pressure (the top number in a blood pressure reading) in patients with uncontrolled and resistant hypertension.
- Researchers are investigating the effects of Baxdrostat on 24-hour ambulatory blood pressure monitoring, which provides a more comprehensive picture of a person's blood pressure throughout the day and night.
- Studies are also looking at how Baxdrostat affects various aspects of heart function, including heart rate and electrical activity of the heart (as measured by ECG).
Dosage and Administration
In clinical trials, Baxdrostat is being tested at different doses, typically ranging from 1 mg to 2 mg taken orally once daily. The optimal dosage may vary depending on individual patient factors and will be determined based on the results of ongoing studies.
Potential Side Effects and Safety Considerations
As with any medication, Baxdrostat may cause side effects. While the full safety profile is still being established through clinical trials, some potential areas of concern include:
- Effects on cortisol levels: Researchers are studying how Baxdrostat might affect the body's stress hormone, cortisol.
- Changes in electrolyte balance: Given its mechanism of action, Baxdrostat could potentially affect levels of potassium and sodium in the body.
- Blood pressure changes: While the goal is to lower high blood pressure, monitoring is important to ensure blood pressure doesn't drop too low.
It's important to note that as Baxdrostat is still in clinical trials, not all potential side effects may be known at this time. Patients participating in trials are closely monitored for any adverse events.
Drug Interactions
Researchers are studying how Baxdrostat interacts with other medications. Some specific interactions being investigated include:
- Itraconazole: This antifungal medication is being used to study how drugs that affect certain liver enzymes might interact with Baxdrostat.
- Oral contraceptives: Studies are examining whether Baxdrostat affects the levels of hormones in birth control pills.
These studies will help determine if any special precautions or dosage adjustments are needed when taking Baxdrostat with other medications.